Researchers have identified a new benchmark for starting drug treatment for AIDS, according to a report published online last week in the journal Lancet.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies (The Lancet)